rs1048990 — PSMA6 PSMA6 -8C>G

PSMA6 -8C>G — When the Cellular Rubbish Collection Drives Inflammation

Every cell in your body runs a continuous protein quality-control operation called the ubiquitin-proteasome system (UPS)¹¹ ubiquitin-proteasome system (UPS)
The UPS tags damaged or misfolded proteins with ubiquitin chains and feeds them to the proteasome — a barrel-shaped multi-subunit protease — for destruction. It also controls the half-lives of regulatory proteins, including the inhibitors of inflammatory signalling. The 20S core proteasome is assembled from alpha and beta subunits; PSMA6 encodes the alpha-6 subunit, which forms part of the outer rings that gate substrate entry. The rs1048990 variant sits just eight bases upstream of the translation start in the 5'UTR of PSMA6 exon 1 — a location that has a quiet but measurable effect on how much PSMA6 protein the cell produces.

The G allele enhances PSMA6 transcription²² enhances PSMA6 transcription
Demonstrated by reporter assays and confirmed by the correlation between genotype and mRNA expression levels across multiple population cohorts. More PSMA6 means more assembled proteasomes, and more proteasome activity accelerates the degradation of IκB — the inhibitor of NF-κB³³ IκB — the inhibitor of NF-κB
IκB normally sequesters NF-κB in the cytoplasm, preventing it from driving expression of inflammatory cytokines (TNF-α, IL-1β, IL-6). When IκB is phosphorylated after an immune stimulus, it is tagged for proteasomal degradation. More proteasomes degrade phospho-IκB faster, releasing NF-κB to the nucleus more readily. The result is a lower threshold for inflammatory gene expression — not a dramatic immune deficiency, but a subtle amplification of the inflammatory signal across the lifetime.

The Mechanism

The -8C>G substitution does not change any protein but alters the regulatory architecture of the PSMA6 5'UTR. Functional studies demonstrated that PSMA6 knockdown using siRNA reduced NF-κB activation by stabilising phosphorylated IκB in cultured cells⁴⁴ Functional studies demonstrated that PSMA6 knockdown using siRNA reduced NF-κB activation by stabilising phosphorylated IκB in cultured cells
The experiment directly connects proteasome abundance to NF-κB activity: less proteasome → slower IκB degradation → more IκB retained → less NF-κB in the nucleus → less inflammatory gene expression. Conversely, the G allele's enhanced transcription runs this pathway in the opposite direction — faster IκB turnover, lower threshold for NF-κB activation, and greater cytokine output in response to inflammatory stimuli.

This mechanism is relevant across multiple disease contexts: chronic low-grade inflammation drives atherosclerosis and plaque instability in cardiovascular disease, and overactive NF-κB signalling is a central feature of autoimmune conditions including rheumatoid arthritis, SLE, and psoriasis.

The Evidence

The original discovery study⁵⁵ The original discovery study
Ozaki K et al. A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population. Nat Genet. 2006 found the G allele in 2,592 MI cases and 2,851 controls from Japan, with striking significance (chi²=21.1, p=4.4×10⁻⁶) and a minor allele frequency of ~0.35 in this population — much higher than in Europeans (~0.17). Replication was confirmed in an independent Japanese cohort.

A meta-analysis pooling 15,991 cases and 16,784 controls⁶⁶ meta-analysis pooling 15,991 cases and 16,784 controls
Wang M et al. Quantitative assessment of the influence of PSMA6 variant (rs1048990) on coronary artery disease risk. Mol Biol Rep. 2013 found a per-G-allele OR of 1.09 (95% CI 1.02–1.16, p=0.006) globally, with the GG homozygous recessive model yielding OR 1.38 (1.22–1.57). The effect was significant in East Asians but did not reach significance in Europeans when analysed separately — likely because GG homozygotes are far rarer in European populations (~2% vs ~9% in Japanese), reducing statistical power.

A UK replication study in 6,946 MI cases and 2,720 controls⁷⁷ A UK replication study in 6,946 MI cases and 2,720 controls
Balmforth AJ et al. The exon 1-8C/G SNP in the PSMA6 gene contributes only a small amount to the burden of myocardial infarction. Atherosclerosis. 2008 confirmed the GG homozygote frequency is far lower in Europeans (2.1% vs 8.9% in Japanese) and that the individual-study result was non-significant, but the combined meta-analysis consistently returned OR ~1.15 per G allele and OR ~1.38 for GG in the recessive model.

Beyond cardiovascular disease, rs1048990 has been associated with type 1 diabetes⁸⁸ type 1 diabetes
OR 2.04, 95% CI 1.38–3.03, p<0.001 in a Latvian cohort, with expression correlates across 14 UPS-related genes, juvenile idiopathic arthritis⁹⁹ juvenile idiopathic arthritis
Polish children study with PSMA6 rs1048990 significant for JIA specifically, and psoriasis¹⁰¹⁰ psoriasis
PSMA6 -8C>G among significant variants in Polish adult psoriasis patients. A male-specific association with asthma was also found in Lithuanian patients, consistent with sex-differential NF-κB signalling.

The breadth of associations across inflammatory and autoimmune phenotypes is expected from a variant that modulates a master inflammatory transcription factor, though the effect size at any single locus is modest (OR 1.1–1.4), fitting a complex polygenic architecture.

Practical Implications

The G allele's elevated NF-κB tone is not manageable through generic anti-inflammatory strategies (these are excluded per platform rules), but there are genotype-specific consequences worth acting on. GG homozygotes carry the highest cardiovascular inflammatory burden. CG heterozygotes carry intermediate risk. The most actionable areas are cardiovascular biomarker monitoring — since the mechanism is inflammatory plaque instability — and awareness of the autoimmune associations for early detection.

Interactions

PSMA6 encodes one of 14 alpha-subunit isoforms of the 20S proteasome. Other proteasome subunit genes have been studied alongside rs1048990: rs2277460 in PSMA6 (a second variant in the same gene), rs2295826 and rs2295827 in PSMC6 (a 19S regulatory particle ATPase), and rs2348071 in PSMA3. Haplotypes spanning PSMA6 and the neighbouring KIAA0391 gene cluster on chromosome 14q13 show stronger associations with coronary artery disease than rs1048990 alone. Individuals carrying risk alleles across multiple proteasome subunit loci may have compounded NF-κB dysregulation, though published compound heterozygosity data remain limited.